CYP cynata therapeutics limited

Pastrami and rye please cynata., page-64

  1. 117 Posts.
    Dr Ross Macdonald, Managing Director and CEO, will present and take part in a fire-side discussion with leading industry analyst, Dr Reni Benjamin of Raymond James, to showcase the Company’s regenerative medicine platform, Cymerus™, and to discuss the positive progress in Cynata’s Phase I clinical trial.

    Senior Biotechnology Analyst - To help build a healthcare vertical covering small and mid-cap biotechnology companies with significant upside potential.

    Plenty of M&A/Raising's from Raymond James...
    https://www.raymondjames.com/corporations-and-institutions/investment-banking/transaction-history
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
1.2¢
Change
0.000(0.00%)
Mkt cap ! $2.921M
Open High Low Volume
1.2¢ 1.2¢ 1.2¢ 76.87K

Buyers (Bids)

Vol. Price($)
178714 1.2¢
 

Sellers (Offers)

Price($) Vol.
1.3¢ 675734
Last trade - 10.05am 29/07/2026 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.